Dr. Moneeb Ashraf
MBBS, M. Phil, CMT

Associate Professor
Department Of Pharmacology

Dr. Moneeb Ashraf


Pharmacology & Therapeutics as a subject acts as a foundation stone on which the entire clinical empire is based. Ever since its inception in 1871, the premier health institution, Mayo Hospital, had been harboring Hakim Classs which was introduced for people with some knowledge of the Unani System with a general emphasis on Anatomy and Surgery. In 1883, as the number of students increased, a professor was appointed for the faculty of Materia Medica (now known as Pharmacology) & Pathology. The training classes for the Ward Boy and compounders were introduced in 1894 and 1901, respectively. During 1906-11, the Chemical Examination Department was shifted from the college and hence its several rooms got vacated where a separate department of Materia Medica was established. The Principal of this prestigious institute, Dr. Nelson Harper, in 1935, ardently emphasized the construction of a separate building for the Pharmacology and hence in 1937, the Pharmacology department was constructed.

Prof. Col. Rai was crowned as the first head of the department. Later, Prof. Amir Chand succeeded him as the next head of the Pharmacology department. Then the renowned physician Col, Ilahi Bukhsh headed the department from 1937 to 1947. During this period, the Pharmacy department of the Punjab University, Lahore started working in K.E. Medical College, but later on, it was shifted back to its original Alma mater in 1950.


The Department of Pharmacology and Therapeutics at King Edward medical university is providing holistic, integrated medical education that enables health professionals to use medicines judiciously and effectively in the community, promote safe and rational use of medicines in the community with due regard to scientific, social, and ethical considerations.  The goals of this department are;

  • To strengthen medical education in relation to Pharmacology for medical health care professionals including dental, nursing, and other paramedical fields.
  • To provide services related to use of medicines for better patient care.
  • To disseminate information and guidance for rational use of medicines.
  • To provide research facilities in basic and clinical Pharmacology.
  • To create resources for use in education and research.


List of Faculty Members

NameDesignationQualificationContact Information
Dr. Moneeb AshrafAssociate ProfessorMBBS, M. Phil,
Dr. Javeria SarfrazAssistant ProfessorMBBS, M.
Dr. Hina AslamAssistant ProfessorMBBS, M.
Dr. Afzaal
Dr. Sadaf Humayun
Dr. Zainab
Dr. Kanwal AhmedPharmaceutical ChemistPharm

The existing Pharmacology and Therapeutics department is actively involved in teaching MBBS undergraduates since the day of its emergence. The BDS 2nd year class of de, Montmorency College of Dentistry is attached to the department for the last 76 years. The classes of nurses and dispensers were also conducted in the department as well. With the uplifting of KEMC to KEMU in 2006, different postgraduate classes and research projects have been initiated like M.Phil and PhD.

  • MBBS
  • BDS
  • Doctor of Physiotherapy
  • B.Sc. – Allied Health Sciences
  • M.Phil (Pharmacology)
  • PhD

In order to keep our teachers abreast with the modern trends in the subject, a Journal Club Meeting is being held regularly, where research papers related to the techniques & methodology of the experimental pharmacology are presented.



Sr. No.AuthorTitleJournal
1Dr. Moneeb Ashraf


Knowledge, Attitude and practical of clinicians about antimicrobial stewardship and resistance among hospitals of pakistan: a multicenter cross-sectional studyEnvironmental Science And Pollution Research International
2Dr. Moneeb Ashraf


A quadruple blinded placebo controlled randomised trial to evaluate the effectivences of an iodine complex for patients with mild to moderate covid-19 in PAISTAN (1-covid-pk):a structured Summary Of A Study  PROTOCOL FOR A RANDOMISED CONTROLLED TRIALTrials


Dr. Moneeb Ashraf


Anti- COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients:

A structured summary of a study protocol for a randomized controlled trial.

4.Dr. Moneeb Ashraf


Prophylactic potential of honey and Nigella sativa L. against hospital and community-based –CoV-2 spread: astructured summary of a study protocol for a randomized controlled trialTrials
3Dr. Javeria SarfrazComparative evaluation of aloe Vera and Diclofenac on body weight blood pressure and renal function of hypertensive ratsProceedings


4Dr. Javeria SarfrazComparison of berberine and dexamethasone on blood and bronchial inflammatory cells of ovalbumin sensitized guinea pigsEsculapio-Journal Of Services Institute Of Medical Sciences
5Dr. Javeria SarfrazEffect of deer velvet antler on airway inflammatory in ovalbumin sensitized guinea pigsAnnual of Punjab Medical College
6Dr. Hina AslamComparative assessment of drug interactions among public and private sector hospitalsPJMHS
7Dr. Sadaf Humayun khanConservative management of thyroid eye diseaseJournal College Of Physicians And Surgeon


1.Evaluation of cardioprotective effect of citric acid against isoproterenol induced myocardial infarction in rabbits.
(Dr. Hafiz Muhammad Imran Aziz)
2.Evaluation of hepatoprotective effect of argyrolobium roseum (jaub and spach) on ccl4 induced hepatotoxicity in rabbits.
(Dr. Nazia Qamar)
3.Protective effect of zinc sulfate, silymarin and their combination against isoniazid and rifampicin induced hepatotoxicity.
(Dr. Wardah Siddique)
4.Nephroprotective evaluation of Citrullus lanatus (water melon) seeds in aminoglycoside induced nephrotoxicity in albino rats.
(Dr. Nelofar Yousaf)
5.Evaluation of antihyperlipidemic effect of zinc sulphate alone and in combination with atorvastatin in diet induced hyperlipidemic rats.
(Dr.Haseeba Talat)
6.Therapeutic effects of canagliflozin and zinc sulphate alone and in combination on diabetes mellitus and associated dyslipidemia in type 2 diabetic rat model.
( Dr.Ayela Eman Zia)
7.The anti-inflammatory effect of (foeniculum vulgare)fennel on the mouse model of ovalbumin induced allergic airway inflammation.
(Dr. Umar Talha)
8.Evaluation of combined anti rheumatic effect of berberine and leflunomide in murine model of rheumatoid arthritis.
(Dr. Shujia Batool)

Work in progress:

1Combined protective effect of omega 3 and coenzyme Q10 in amoxicillin clavulanic acid induced hepatotoxicity in rats.
(Dr. Seemel Taimur)
2Preventive effect of mesalazine and co-enzyme Q10 alone and in combination in rat model of dextran sulfate sodium induced ulcerative colitis.
(Dr. Hanna Pirzada)
3Comparative gastro-protective effect of probiotics & misoprostol on aspirin induced gastric ulcer in rat model.
(Dr. Rabia Rafique)
4Effect of aloe vera gel on atorvastatin induced hepatotoxicity in hyperlipidemic rat model.
(Dr. Namra Iqbal)
5Therapeutic effects angiotensin receptor blocker and selenium alone and in combination on streptozocin induced diabetic nephropathy in rat model.
(Dr. M. Usama)
6Comparative gastro-protective effect of probiotics & misprostol in aspirin induced gastric ulcer in rat model.
(Dr. Rida Naseer)
7Preventive effects of cinnarzine and olmesrtan alone and in combination on dextran sulfate sodium induced ulcrative colitis in rat model.
(Dr. Hira Sohail)
8Combine effect of CoQ10 and zinc on diclofena induced hepatotoxicity in rat model
(Dr. Binish Anwer)
9Effect of Ranolazine glycemic control and dyslipidemia alone and in combination with metformin in streptozocin induced type 2 diabetic rat model.
(Dr. Attiya Kanwal)

The new building is expected to have the following facilities;

  1. Postgraduate Laboratory
  2. Therapeutic drug monitoring
  3. Museum
  4. Pharmaco vigilance center
  5. The Animal House constructed on modern design with sufficient provisions like keeping, housing, breeding, rearing and confining of different species of animals required for research purposes.

In future the following patient care facilities are planned to take place in the department;

  • Formulation and implementation of Drug policy of GOP
  • Selection and formulation of the list of Essential medicines
  • National Antimicrobial Policy formulation
  • Provincial vector borne disease control programme
  • Promotion of rational use of medicines
  • Monitoring of adverse drug reactions